Merck (MRK) EBITDA Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Merck (MRK) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.20 Bn | 622.44 Bn | 17.26 Bn |
| 2 | AbbVie | 448.14 Bn | 441.57 Bn | 12.70 Bn |
| 3 | Merck | 358.13 Bn | 350.98 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.12 Bn | 11.24 Bn |
| 5 | Pfizer | 156.55 Bn | 144.85 Bn | 10.94 Bn |
| 6 | Sanofi | 52.17 Bn | 44.78 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.92 Bn | 42.92 Bn | - |
| 8 | Incyte | 24.72 Bn | 20.19 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.83 Bn | 15.44 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,734.00 |
| Mar 31, 2026 | -6,712.00 |
| Dec 31, 2025 | 860.00 |
| Sep 30, 2025 | 608.00 |
| Jun 30, 2025 | -620.00 |
| Mar 31, 2025 | 1,028.00 |
| Dec 31, 2024 | 392.00 |
| Sep 30, 2024 | -1,396.00 |
| Jun 30, 2024 | 180.00 |
| Mar 31, 2024 | 2,098.00 |
| Dec 31, 2023 | -2,124.00 |
| Sep 30, 2023 | 7,034.00 |
| Jun 30, 2023 | -6,015.00 |
| Mar 31, 2023 | 95.00 |
| Dec 31, 2022 | -196.00 |
| Sep 30, 2022 | -693.00 |
| Jun 30, 2022 | -127.00 |
| Mar 31, 2022 | 858.00 |
| Dec 31, 2021 | -1,017.00 |
| Sep 30, 2021 | 2,246.00 |